Chiron, a business of Novartis Vaccines and Diagnostics, has a legacy of leadership in blood safety since 1986, when Chiron scientists first identified the hepatitis C virus leading to the development of the first test to screen blood for HCV.
Select your location below for the latest news and information on Chiron and the PROCLEIX® line of nucleic acid testing (NAT) products for blood screening.